PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20159824-0	2010	Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy.	Ketoconazole	171-183	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	30-35